Últimas noticias sobre Napatech (OTC:NPTSF) Bolsa

Napatech AS is a tech company. It enhances open and standard virtualized servers to boost innovation and release valuable computing resources that improve services and increase revenue. The Group manufactures and sells network adapters to end-users and through third-party channel partners. It derives maximum of its revenue from the Americas.

Napatech AS

Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) has outperformed the market over the past 10 years by 1.4% on an annualized basis producing an average annual return of 11.03%. Currently, Globus Medical has a market capitalization of $9.94 billion. 
Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $2,828.51 today based on a price of $72.30 for GMED at the time of writing.
<h3>Globus Medical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744903831_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

GMED

Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years

IPOs

Chagee IPO Price Indicating $33.60/ADS; IPO Priced At $28/ADS On 14.68M Shares

The <a href="https://www.benzinga.com/topic/artificial-intelligence">AI-fueled rally</a> in semiconductors just ran into a geopolitical buzzsaw. NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) disclosed this week that the U.S. government has imposed new license requirements for selling their AI-focused chips — Nvidia&#8217;s H20 and AMD's MI308 — to China, Hong Kong, Macau and several D:5 countries.
Nvidia responded with a $5.5 billion inventory charge, effectively bracing for a complete block in shipments. AMD booked an $800 million hit of its own. JPMorgan analyst Harlan Sur estimates that these curbs will shave off 8%-10% of both companies&#8217; earnings this year.
Read Also: <a href="https://www.benzinga.com/markets/25/04/44858727/jensen-huang-in-china-for-talks-as-us-tightens-nvidia-chip-restrictions-report">Jensen Huang In China For Talks As US Tightens Nvidia Chip Restrictions: Report</a>
<h1 class="wp-block-heading">The China Revenue Stream? Drying Up Fast</h1>
Nvidia's China data center business previously contributed a low-teens percentage to its overall data center revenue. With H20 shipments now in limbo, Sur expects that number to fall to "a de minimis level."
AMD, meanwhile, faces an estimated $1.5–$1.8 billion revenue impact on the back of the $800 million inventory charge. That's roughly 10% of its expected data center sales this year, noted Sur. The fallout isn't confined to the second quarter &#8211; the guidance hit spans all of 2025.
<h1 class="wp-block-heading">Winners, Losers — And The Silicon Side Effects</h1>
Sur believes there's still heavy AI demand in China — but now Chinese firms may accelerate a pivot to domestic alternatives like Huawei's Ascend chips or custom ASICs. In a surprising silver lining, custom AI ASIC projects remain unaffected by the new rules.
That's good news for players like Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), which continues to ramp up shipments for its third major custom AI customer. As it stands, merchant solutions like Nvidia and AMD's GPUs are feeling the heat, while bespoke chips enjoy relative regulatory immunity — for now.
With new AI diffusion rules starting mid-May and a looming Section 232 probe on imported chips, this may be just the opening chapter of a longer regulatory saga for U.S. semiconductor giants.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44861917/broadcom-marvell-synopsys-the-chips-that-might-not-crumble-in-the-coming-storm">Broadcom, Marvell, Synopsys: The Chips That Might Not Crumble In The Coming Storm</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Global

Analyst Ratings

Tech

AVGO

NVDA

Nvidia, AMD Take A $17 Billion Hit In The AI Arms Race, While Broadcom Remains Shielded, Says Analyst

ADGM

Adagio Medical Shares Resume Trade

JNVR

Janover Shares Resume Trade

Guggenheim analyst Joseph Osha reiterates Itron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) with a Buy and maintains $133 price target.

Price Target

Reiteration

ITRI

Guggenheim Reiterates Buy on Itron, Maintains $133 Price Target

Editor&rsquo;s note: This article was originally published in May 2024. Some time references have been adjusted for clarity.
&ldquo;Endometriosis made me want to jump off a building,&rdquo; <a href="https://elplanteo.com/tiffany-haddish-marihuana-salud-berner/">Tiffany Haddish</a> admits candidly, revealing the extent of her chronic pain. For Haddish, <a href="https://www.benzinga.com/cannabis">cannabis</a> has been a vital tool for coping with the relentless agony she faces during her menstrual cycle. Her voice carries real gravitas as she describes how smoking marijuana helps relieve the physical pain she has suffered for years. &ldquo;When I discovered the actual power of marijuana and how it can help relieve that inflammation, bring that pain down&hellip; It has helped me so much,&rdquo; she explains. &ldquo;I went to Panama and learned about the different things that cannabis can do and how you can use it. I like mixing it [cannabis leaves] with coconut water and making tea out of the flower.&rdquo;
Haddish isn&#39;t a stranger to cannabis. She first tried it at 18 but found herself overwhelmed with laughter and discomfort. &ldquo;I didn&#39;t like that. I couldn&#39;t stop laughing. So I was like, &lsquo;I&#39;m not messing with this,&rsquo;&rdquo; she voices.
She returned to the herb later, in her early twenties, while navigating emotional turmoil. &ldquo;I had a choice between some weed and some other drug. And I chose the weed because I felt like that was a card, versus the other thing that was sitting on the table there,&rdquo; she says. From that moment on, marijuana has played a significant role in her life, evolving from an occasional escape to a reliable source of relief during her most painful times. &ldquo;It made me feel relaxed. It took away a lot of my emotional pain. At first, it was like an occasional thing. Then, as I experienced endometriosis pain, especially during my cycles, during my period, I would smoke weed basically for a week straight while I was bleeding. And that changed the game for me. I was able to function. I wasn&#39;t like crying and super emotional all the time,&rdquo; she adds.
The comedian has long been outspoken about the ways in which cannabis has positively impacted her life. She&rsquo;s not shy about the medical benefits, recounting how cannabis has helped her manage pain and improve her overall well-being.
<h3>Cannabis And Endometriosis</h3>
The use of cannabis to manage endometriosis has garnered interest in recent years, with research offering promising insights into its efficacy. A study published in the&nbsp;<a href="https://www.sciencedirect.com/science/article/abs/pii/S1701216319308084" rel="nofollow noopener noreferrer" target="_blank" title="https://www.sciencedirect.com/science/article/abs/pii/S1701216319308084">Journal of Obstetrics and Gynaecology Canada</a>&nbsp;surveyed Australian women with surgically confirmed endometriosis, revealing that 13% of them turned to cannabis as a self-management strategy for symptom relief. The study showed that cannabis was particularly effective in reducing pain, with a self-reported effectiveness score of 7.6 out of 10, and 56% of women who used cannabis were able to reduce their reliance on pharmaceutical medications by at least half. Participants also reported improvements in sleep, nausea and vomiting, with few adverse effects observed.
Studies published through 2023 have further investigated the potential of cannabis in treating endometriosis-related pain and its associated symptoms. A review published in the&nbsp;<a href="https://www.news-medical.net/news/20231114/Cannabis-shows-promise-in-easing-endometriosis-pain-new-research-suggests.aspx" rel="nofollow noopener noreferrer" target="_blank" title="https://www.news-medical.net/news/20231114/Cannabis-shows-promise-in-easing-endometriosis-pain-new-research-suggests.aspx">Journal of Clinical Medicine</a>&nbsp;analyzed existing research on cannabis use for endometriosis, uncovering promising mechanisms where cannabinoids interact with the endocannabinoid system (ECS) and the gut microbiome to alleviate symptoms. The review highlighted that cannabis-derived compounds can have anti-inflammatory effects, decrease gut permeability, and act as natural painkillers, offering significant relief from bloating, a common endometriosis symptom. Another study published in&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547625/" rel="nofollow noopener noreferrer" target="_blank" title="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547625/">PLOS One</a>&nbsp;collected data from over 250 participants with self-reported endometriosis, recording more than 16,000 cannabis use sessions. The results indicated that cannabis effectively reduced pelvic pain and improved gastrointestinal symptoms and mood, with inhaled cannabis showing quick pain relief, while oral ingestion had a longer-lasting effect for mood-related symptoms.
In Haddish&rsquo;s view, many women are suffering silently due to a lack of understanding and awareness about conditions like hers. Cannabis, for her, offers a viable solution. &ldquo;I think it&#39;s not talked about widely because men don&#39;t get endometriosis. If men got endometriosis, it would probably be something talked about&hellip; You need to give women the right to be able to smoke or ingest cannabis legally&hellip; If you are going to take the right for women to make the decisions off of their uterus, then you need to give them the right to be able to smoke or ingest cannabis legally, completely across the board,&rdquo; she says.
<h3>Acting Through The Pain</h3>
&ldquo;That&#39;s why I think I&#39;m a phenomenal actress; I learned how to act through the pain, but I&#39;m dying on the second day [of my cycle],&rdquo; Haddish asserts, emphasizing the toll endometriosis took on her daily life. Smoking marijuana made it possible for her to function during those difficult times. Over the years, she became more conscious of the ways cannabis could enhance her health.
For Haddish, cannabis is also key in managing other health issues. She shares stories of friends who have multiple sclerosis. Initially, they were against marijuana, she says, but medical advice convinced them to try it. They quickly experienced improved mobility and communication. This is why Haddish highlights how cannabis can help those with health challenges in moderation and when used with purpose.
&ldquo;I&#39;ve never hid my cannabis use from anybody &ndash; except for maybe my grandma. And then I did a TV show way back in 2008. And, I know she knew, cause she could see the roaches in the ashtray, but that I would try to hide under the bed and stuff when she would come to my house,&rdquo; Haddish says with a chuckle.
Despite her love for cannabis, Haddish has had to change how she consumes it. As of mid-2024, she had stopped using THC due to testing requirements but remains unperturbed. &ldquo;I haven&#39;t experienced any withdrawal symptoms,&rdquo; she notes, adding that she&#39;s still able to enjoy the other benefits of cannabis through non-THC products like teas and other extracts.
<h3>A Freaky Collaboration</h3>
Cookies, the influential cannabis brand co-founded by rapper and entrepreneur&nbsp;<a href="https://elplanteo.com/berner-enamoro-cannabis-musica/" target="_self" title="https://www.forbes.com/sites/javierhasse/2020/09/16/berner/?sh=469493b9541d">Berner</a>, teamed up with TV show &ldquo;The Freak Brothers&rdquo; in 2024 for a unique collaboration that merged cannabis culture with entertainment. For Berner, stepping into the world of &ldquo;The Freak Brothers&rdquo; felt surreal. &ldquo;It&rsquo;s a real trip to see myself in the Freaksverse alongside entertainers I&rsquo;ve looked up to for a while,&rdquo; he remarked, appreciating the chance to blend his passion for cannabis with a project that has such deep roots in counterculture.
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" frameborder="0" height="315" src="https://www.youtube.com/embed/91Gp4tKYktU?si=acfqEqrzGjjLS6iG" width="560"></iframe>
The original &ldquo;The Freak Brothers&rdquo; comic series, created by Gilbert Shelton in the late 1960s, carries a legacy that continues to shape cannabis culture today. Known for its counterculture humor and satirical take on stoner life, the comic found a new home as an adult animated series, featuring a cast that includes Haddish,&nbsp;<a href="https://www.forbes.com/sites/lindseybartlett/2022/05/16/woody-harrelson-talks-cannabis-at-the-woods-dispensary-opening/?sh=273571555c45" target="_self" title="https://www.forbes.com/sites/lindseybartlett/2022/05/16/woody-harrelson-talks-cannabis-at-the-woods-dispensary-opening/?sh=273571555c45">Woody Harrelson</a>, John Goodman, Pete Davidson and Berner. This modern incarnation pays homage to the series&#39; roots while bringing it into the contemporary world of cannabis and entertainment.
<img alt="Cookies x 'The Freak Brothers'" src="https://imageio.forbes.com/specials-images/imageserve/66327a9fcd7689830eb246af/Cookies-x--The-Freak-Brothers-/960x0.jpg?format=jpg&amp;width=1440" style="height:450px; width:360px" />
Cookies x &#39;The Freak Brothers&#39;. COURTESY OF COOKIES
In tandem with the TV show, Cookies and &ldquo;The Freak Brothers&rdquo; released a special joint, aptly named the &ldquo;LSD Joint.&rdquo; The collaboration behind this product reflected the shared ethos of both brands. As Berner explained, &ldquo;The synergy was undeniable &mdash; kind of like an old school meets new school vibe with us both being from The Bay.&rdquo; The limited-edition product aimed to create something the original Freaks themselves would&rsquo;ve enjoyed in the &#39;60s and &#39;70s &mdash; and quickly became a fan favorite before selling out.
&ldquo;With the Freaks being a real trippy crew, we just knew we needed to put something out that the Freaks themselves would have loved to spark up back in the 60s and 70s,&rdquo; the rapper added.
Although the Cookies x Freak Brothers collab is no longer available, it remains a vivid illustration of how far cannabis culture has come. It stands as a testament to the evolving perception of cannabis in popular media, where the lines between entertainment and advocacy are increasingly blurred.
Berner was enthusiastic about the cultural shift that allowed a stoner show like &ldquo;The Freak Brothers&rdquo; to reach the mainstream. &ldquo;Man, I love to see more mainstream entertainment embracing the culture, it&rsquo;s about time,&rdquo; he said.
<h3>&lsquo;If You&rsquo;re Lazy, You&rsquo;re Lazy&rsquo;</h3>
Navigating the shifting terrain of cannabis acceptance, Haddish embodies a spirit of authenticity and openness that resonates deeply within the community. She&rsquo;s quick to counter negative stereotypes around cannabis users, especially those who assume it leads to laziness or a lack of productivity. &ldquo;If you&rsquo;re lazy, you&rsquo;re lazy. Period,&rdquo; she asserts, noting how cannabis can be an integral part of a balanced, healthy lifestyle.
&ldquo;There are lots of very productive, business-minded, business-oriented, resolute people that smoke or ingest marijuana in some sort of way, shape or form,&rdquo; she adds, emphasizing how many successful individuals incorporate cannabis into their lives without compromising their productivity.
Haddish doesn&#39;t hesitate to highlight the contrasting effects of alcohol and cannabis, suggesting that alcohol should be illegal due to its negative impacts on society. &ldquo;There&rsquo;s a lot of domestic violence because of alcohol. A lot of child abuse because of alcohol, but not because of weed,&quot; she points out. For Haddish, cannabis promotes relaxation and calm, in stark contrast to the aggression often linked to alcohol consumption.
By means of conclusion, the actress emphasizes the importance of intent in usage, urging people to understand their purpose for consuming cannabis and to align it with their goals, whether for sleep, pain management, or&nbsp;<a href="https://www.forbes.com/health/mind/what-is-anxiety/" target="_self">anxiety</a>&nbsp;relief. She strongly believes in legalization, particularly for women. In her view, there are many misconceptions about cannabis, and &ldquo;a lot of women are in jail right now, because of endometriosis, because it will make you make some poor decisions.&rdquo;
&ldquo;But I&#39;ve never seen nobody try to hurt anybody or fight anybody after taking in a little bit of marijuana,&rdquo; she ends.
Follow me on&nbsp;<a href="https://www.twitter.com/javierhasse" rel="nofollow noopener noreferrer" target="_blank">Twitter</a>&nbsp;or&nbsp;<a href="https://www.linkedin.com/in/javierhasse/" rel="nofollow noopener noreferrer" target="_blank">LinkedIn</a>.&nbsp;Check out&nbsp;my&nbsp;<a href="https://elplanteo.com/" rel="nofollow noopener noreferrer" target="_blank">website</a>&nbsp;or&nbsp;some of my other work&nbsp;<a href="https://benzinga.com/cannabis" rel="nofollow noopener noreferrer" target="_blank">here</a>.&nbsp;
This article was originally published on <a href="https://www.forbes.com/sites/javierhasse/2024/05/01/i-chose-weed-over-drugs-tiffany-haddish-calls-for-cannabis-legalization-for-womens-health-talks-berner-collab/">Forbes </a>and appears here with permission.&nbsp;The article is from an external source. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.
Lead image courtesy of &quot;The Freak Brothers.&quot;

Cannabis

Health Care

Markets

Interview

General

Tiffany Haddish: 'If Men Had Period Pain, Weed Would Already Be Legal'

Adagio Medical Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Up 136.1%

Janover Shares Halted On A Circuit Breaker To The Downside; Stock Now Down -34.6%

WIIM

TLRY

Tilray Brands shares are trading lower after the company announced it will vote to implement a reverse stock split, potentially upwards of a 1-to-20 basis.

DXCM

TNDM

Shares of diabetes stocks are trading lower following successful obesity data from Lilly.

Loop Capital analyst Chris Dankert maintains Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) with a Buy and lowers the price target from $320 to $290.

Loop Capital Maintains Buy on Applied Industrial Techs, Lowers Price Target to $290

TFIN

Triumph Financial shares are trading lower after the company reported worse-than-expected Q1 revenue results.

IIIN

Insteel Industries shares are trading higher after the company reported a Q2 revenue beat.

Badget Meter shares are trading higher after the company reported Q1 financial results and beat its EPS and sales estimates.

SMCI

Super Micro Computer shares are trading lower after JP Morgan cut its price target on the stock from $45 to $39.

U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/USB/earnings">earnings on Wednesday.</a>
The company posted earnings per share of $1.03, which beat the analyst consensus estimate of 98 cents. The parent company of U.S. Bank reported quarterly revenues of $6.95 billion. It outpaced the analyst consensus estimate of $6.91 billion.
U.S. Bancorp's average total loans increased 2.1% on a year-over-year basis and 0.9% on a linked quarter basis.
"We managed expenses with discipline and delivered 270 basis points of positive operating leverage on an adjusted basis – our third consecutive quarter of yearover-year growth in revenues outpacing expenses," said U.S. Bancorp CEO Gunjan Kedia.
U.S. Bancorp shares gained 1.6% to trade at $38.40 on Thursday.
These analysts made changes to their price targets on U.S. Bancorp following earnings announcement.
<ul>
<li>Keefe, Bruyette &amp; Woods analyst David Konrad maintained U.S. Bancorp with a Market Perform rating and lowered the price target from $54 to $49.</li>
<li>Truist Securities analyst John McDonald maintained the stock with a Hold rating and cut the price target from $51 to $48.</li>
<li>Barclays analyst Jason Goldberg maintained U.S. Bancorp with an Overweight rating and lowered the price target from $61 to $56.</li>
</ul>
Considering buying USB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-1024x598.png" alt="" class="wp-image-877017" style="width:531px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26.png 1067w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44866413/netflix-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-3">Netflix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a> </li>
</ul>
Photo via Shutterstock

Earnings

U.S. Bancorp Analysts Slash Their Forecasts After Q1 Earnings

NDRA

ENDRA Life Sciences Shares Halted On Circuit Breaker To The Upside, Stock Now Up 57.6%

HBAN

Huntington Bancshares shares are trading higher after the company reported better-than-expected Q1 financial results and approved a $1 billion stock repurchase program.

AngloGold Ashanti shares are trading lower after HSBC downgraded the stock from Hold to Reduce and announced a price target of $35.

Napatech

Comments

Napatech

Noticias

Últimas noticias sobre Napatech (OTC:NPTSF) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL